IBD
Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease
Feature
New Approaches to Screening for Barrett Esophagus
Abstract: Current screening methods for Barrett esophagus (BE), the precursor to esophageal adenocarcinoma (EAC), are inadequate with less than one-third of screen-eligible patients currently undergoing screening. […]
From Recent Issues
Feature
New Approaches to Screening for Barrett Esophagus
Abstract: Current screening methods for Barrett esophagus (BE), the precursor to esophageal adenocarcinoma (EAC), are inadequate with less than one-third of screen-eligible patients currently undergoing screening. […]
Feature
From Past to Present: The Evolution of Pharmacologic Therapies for Eosinophilic Esophagitis
Abstract: Within the evolving landscape of eosinophilic esophagitis (EoE) management are multiple pharmacologic treatment modalities, including proton pump inhibitors (PPIs), swallowed topical corticosteroids, and novel biologic […]
Feature
Looking Toward the Future: Emerging Therapies for Hepatocellular Carcinoma
Abstract: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths worldwide. Despite the decreasing prevalence of hepatitis C, the burden of HCC is expected to […]
Supplements
Highlights in IBS-C From Digestive Disease Week 2025
A Review of Selected Presentations From DDW 2025 May 3-6, 2025 • San Diego, California Safety and Tolerability of Tenapanor in Pediatric Patients With IBS-C: […]
Patient-Centered Approach in IBS-C Management
About the Patient CS is a 40-year-old female internist who was referred to my clinic by a colorectal surgeon in February 2025. CS had consulted the […]
Raising Expectations in IBS-C Management
Patient Case CF is a 47-year-old female who presents for a second-opinion evaluation of chronic constipation and abdominal pain (Table 1). Her past medical history is […]